Rogers Corp (ROG) ニュース

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to...

Form 4 - Statement of changes in beneficial ownership of securities

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Rogers Corporation Reports Third Quarter 2024 Results

Improved Operating Margin Drives Further Earnings Growth Rogers Corporation (NYSE:ROG) today announced financial results for the third quarter...

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

Roche receives FDA approval for the first companion diagnostic to identify patients with gastric and...

Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24

Rogers Corporation (NYSE:ROG) (“Rogers”) plans to announce third quarter 2024 results on October, 24, 2024 after market close, which will be...

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public

Survey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities